
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $26.6M | -- | -- | -$0.07 | -- |
08/14/2025 | Q2 | $21.6M | -- | -- | -$0.10 | -- |
05/15/2025 | Q1 | $17M | $21.1M | -$0.14 | -$0.23 | $0.09 |
12/31/2024 | Q4 | $29.6M | $23.5M | -$0.90 | -$0.08 | -$0.82 |
11/15/2024 | Q3 | $26.4M | $26.4M | -$0.18 | -$0.14 | -$0.05 |
08/14/2024 | Q2 | $27M | $28.6M | -$0.38 | -$0.09 | -$0.29 |
05/20/2024 | Q1 | $13.7M | $17.7M | -$0.30 | -$0.29 | -$0.01 |
02/20/2024 | Q4 | $16.5M | $15.6M | -$1.53 | -$0.23 | -$1.30 |
11/15/2023 | Q3 | $22.7M | $11.5M | -$0.42 | -$0.19 | -$0.23 |
08/14/2023 | Q2 | $14.2M | $11.4M | -$0.34 | -$0.32 | -$0.02 |
03/31/2023 | Q1 | -- | $2.8M | -$0.78 | -- | -- |
05/18/2023 | Q1 | -- | $8.9M | -$1.84 | -- | -- |
12/31/2022 | Q4 | $9M | -- | -- | -- | -- |
01/17/2023 | Q4 | -- | $10.3M | -$1.36 | -- | -- |
09/30/2022 | Q3 | $7.6M | -- | -- | -- | -- |
11/23/2022 | Q3 | -- | $11.4M | -$1.32 | -- | -- |
07/14/2022 | Q2 | -- | $9.2M | $1.92 | -- | -- |
04/14/2022 | Q1 | -- | $9M | -$1.72 | -- | -- |
01/13/2022 | Q4 | -- | $12.2M | -$0.32 | -- | -- |
11/23/2021 | Q3 | -- | $10.9M | -$4.08 | -- | -- |
05/31/2021 | Q2 | -- | $8M | -$1.20 | -- | -- |
02/28/2021 | Q1 | -- | $7.7M | -$8.44 | -- | -- |
11/30/2020 | Q4 | -- | $7.5M | -$3.12 | -- | -- |
08/31/2020 | Q3 | -- | $7M | -$5.20 | -- | -- |
05/31/2020 | Q2 | -- | $2.1M | -$14.52 | -- | -- |
02/29/2020 | Q1 | -- | $624K | -$12.84 | -- | -- |
11/30/2019 | Q4 | -- | $808.3K | -$195.60 | -- | -- |
08/31/2019 | Q3 | -- | $205.9K | -$277.39 | -- | -- |
05/31/2019 | Q2 | -- | $800.2K | -$55.72 | -- | -- |
02/28/2019 | Q1 | -- | $1.5M | -$39.60 | -- | -- |
11/30/2018 | Q4 | -- | $1.7M | -$45.00 | -- | -- |
08/31/2018 | Q3 | -- | $1.4M | -$318.57 | -- | -- |
05/31/2018 | Q2 | -- | $1M | $3.74 | -- | -- |
02/28/2018 | Q1 | -- | $533.6K | $45.00 | -- | -- |
11/30/2017 | Q4 | -- | $544.4K | -$90.00 | -- | -- |
08/31/2017 | Q3 | -- | $117.3K | -$315.00 | -- | -- |
05/31/2017 | Q2 | -- | $142.9K | -$135.00 | -- | -- |
02/28/2017 | Q1 | -- | $12.4K | -$45.00 | -- | -- |
11/30/2016 | Q4 | -- | $36.4K | -$90.00 | -- | -- |
09/30/2016 | Q3 | -- | -- | -$0.22 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$13.28 | -- | -- |
05/31/2016 | Q2 | -- | $21.2K | -$90.00 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$9.28 | -- | -- |
02/29/2016 | Q1 | -- | $2.8K | -$45.00 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.10 | -- | -- |
11/30/2015 | Q4 | -- | $12.1K | -$180.00 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$1.58 | -- | -- |
GameSquare Holdings reported $21.1M worth of top line sales in its most recent quarter.
GameSquare Holdings announced earnings per share of -$0.14 which represents a beat of analyst forecast a -$0.23 per share.
GameSquare Holdings reported $3.3M that represents $0.09 per share over the last quarter.
GameSquare Holdings's earnings are forecast to decrease from -$1.75 per share to -$0.92 per share next year representing a decrease of -74.86%.
GameSquare Holdings's next earnings date is August 14, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.